01 Growing Demand Due to the Vast Amount of Data Generated in the Life Sciences SectorAs technology develops, there will be more data that needs to be analyzed. For instance, Next-generation Sequencing (NGS) equipment in the field of genomic research can produce 1 TB of data per hour. The enormous amount of data produced can be used to develop personalized medicine, increase R&D productivity, and evaluate the effectiveness and risks of clinical trials. Additionally, it helps with forecasting profits, budgeting research, and price control. Data can be sent directly from a patient's location to a hospital or healthcare service provider using wearable, implantable, and remote health monitoring devices.The demand for data analysis and storage in the life sciences is expected to rise as the number of implants and wearable devices rises. A new virus can be found with the aid of DNA sequencing. Scientists use this to determine the nucleic acid's sequence. It needs to be put through testing and compared to extensive databases. New technologies like telemedicine, virtual clinical trials, and AI may be widely adopted, opening access to medical research and increasing diversity. The price and time required to produce value from information initiatives are significantly falling thanks to NoSQL databases, Hadoop, and cloud-based platforms.
02 Large-Scale Data Storage and RetrievalThe amount of information doctors have about their patients has increased due to the widespread adoption of electronic health records (EHR). A large portion, if not the entirety, of the patient's medical history is covered in this patient data portfolio, enabling doctors to provide individualized treatment plans and make accurate diagnoses. Health IT departments must provide a more reliable infrastructure to digitize and store tissue sample slides due to the rapid growth in diagnostic information. In addition, pathologists can store, analyze, and share data in real-time by converting these slides into digital files, which enhances collaboration and speeds up clinical decision-making.Applications of genomic data in research, drug development, and precision medicine are growing. Massive amounts of data are produced by next-generation sequencing, which requires effective analysis and storage. As a result, managing the entire lifecycle of genomic data requires storage solutions to be more adept. Further, the value of data is constantly increasing. The processes and tools needed to mine, process, and analyze the data gleaned from these sources must be in place.
01 High Installation Cost and Data SecurityBy gaining access to millions of deep, broad, and loosely connected patient-years of data from various sources (EHR, Digital Data, Imaging, and Genomics), pharmaceutical and life sciences companies are attempting to provide personalized healthcare. The petabyte and zettabyte scales are required to process and analyze data in the pharmaceutical and life sciences industries. However, on-site data centers would be prohibitively expensive because they would need to be built to capacity, requiring a significant upfront investment. In addition, the cost simply does not outweigh the benefit when considering the time required to construct such large-capacity data centers. A potential solution is to move data to the public cloud, which must be done after it has been made secure, breach-proof, and compliant with continuous monitoring capabilities. It is predicted that this will restrain the market growth during the forecast period.
01 Data-Driven Strategic DecisionsCompanies can change procedures and acquire a competitive edge by fusing medical and scientific expertise. It can help design new compounds, accelerate drug development, improve supply chain intelligence and responsiveness, and launch and market products. It can identify and validate genetic drug targets.Furthermore, data issues (28%), integrating AI into the organization (28%), and identifying high-value business cases (30%) are top AI issues. The explosion in healthcare data and advances in cognitive computing and machine learning are expected to increase the use of data analytics along the entire biopharma value chain, from molecule to market. Recent initiatives by GSK (UK), 23&Me (US), Sanofi (France), and Google aim to improve treatment outcomes by better understanding patient populations and diseases genetically.
June 2025 Snowflake announced the acquisition of Crunchy Data, a leading PostgreSQL solutions provider. The acquisition enhances Snowflake's capabilities in transactional data management and analytics, enabling customers to unify operational databases with AI and analytical workloads on a single cloud data platform.
May 2025 Salesforce announced a definitive agreement to acquire Informatica for approximately USD 8 billion. The acquisition is intended to strengthen Salesforce's AI-driven data management, integration, metadata, governance, and master data management capabilities, enhancing enterprise data analysis and storage solutions for AI-powered applications.
May 2025 Boomi announced the acquisition of Thru, Inc., a provider of enterprise Managed File Transfer (MFT) solutions. The acquisition expands Boomi's secure data movement, integration, and governance capabilities, enabling enterprises to manage and exchange critical business data more efficiently across hybrid IT environments.
May 2025 DataCore Software acquired StarWind Software, expanding its hyperconverged infrastructure portfolio for edge, remote office/branch office (ROBO), and SMB deployments. The acquisition strengthens DataCore's storage virtualization and data management offerings for distributed enterprise environments.